Circle Pharma

About:

Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.

Website: http://circlepharma.com

Top Investors: Pfizer, Eli Lilly, Mission BioCapital, The Column Group, Eli Lilly & Company Foundation

Description:

Circle Pharma is an early-stage biotechnology company applying proprietary computational design algorithms and innovative chemistry to develop cell-permeable macrocycle peptide therapeutics against important clinical targets. It does this through an iterative, rational design process that deploys large virtual libraries of conformationally diverse macrocycle scaffolds selected for inherent permeability. The company was founded by Matt Jacobson and Scott Lokey in 2012 and is headed by David J. Earp.

Total Funding Amount:

$208M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)circlepharma.com

Founders:

Matthew Jacobson, Scott Lokey

Number of Employees:

11-50

Last Funding Date:

2024-09-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai